MedTrace Logo

ONS in Gastric Cancer After Total Gastrectomy

NCT05823272 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-22

No results posted yet for this study

Summary

Gastric cancer patients after total gastrectomy will be randomized to oral nutritional supplement group or control group at discharge. Patients will receive 6 months of oral nutritional supplement or normal diet after discharge. The primary and secondary outcomes will be collected.

Conditions

Interventions

OTHER

ONS

oral nutritional supplement

Sponsors & Collaborators

  • Zhongda Hospital

    collaborator OTHER

  • Shandong Provincial Hospital

    collaborator OTHER_GOV

  • Hebei Medical University Fourth Hospital

    collaborator OTHER

  • Zunyi Medical College

    collaborator OTHER

  • Xinqiao Hospital of Chongqing

    collaborator OTHER

  • Jinling Hospital, China

    lead OTHER

Principal Investigators

  • Xinying Wang, MD · Jinling Hosptial

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-22
Primary Completion
2024-08-05
Completion
2024-08-05

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05823272 on ClinicalTrials.gov